You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

McMurtrie v. Iolab Corp.

Citations: 914 F. Supp. 1372; 1995 WL 702525Docket: Civil A. 94-3683 to 94-3688

Court: District Court, E.D. Louisiana; November 29, 1995; Federal District Court

Narrative Opinion Summary

The case involves plaintiffs who filed suit against Dr. Azar and IOLAB Corporation, among others, claiming negligence, strict liability, and fraud related to a Class III intraocular lens device. Initially, the federal district court denied the motion to remand the case to state court, holding that the claims were preempted by federal law under the Medical Devices Amendments (MDA) to the Federal Food, Drug, and Cosmetic Act. However, after the Fifth Circuit clarified preemption issues in Feldt v. Mentor Corp., the court revisited its decision. It concluded that the state law claims for defective design were not preempted, as the specific design requirements were not covered by federal regulations. The court emphasized the similarities with the Feldt case, rejecting the defendants' attempts to distinguish it based on the investigational device exemption. Additionally, the court dismissed reliance on Lewis v. Intermedics Intraocular, Inc., which addressed a distinct issue of informed consent. Consequently, the court vacated its prior order and remanded the consolidated cases, including McMurtrie v. Iolab Corp., back to the 24th Judicial District Court for the Parish of Jefferson, Louisiana, recognizing that the plaintiffs had adequately stated their claims under state law.

Legal Issues Addressed

Application of Precedent from Feldt v. Mentor Corp.

Application: The court found the circumstances in the present case analogous to Feldt, rejecting arguments for federal preemption based on the investigational device exemption and emphasizing that FDA regulations did not preclude state claims.

Reasoning: The court rejected the defendants' attempts to differentiate this case from Feldt, noting that the FDA regulations cited did not impose specific design requirements, which was crucial to the preemption analysis.

Federal Preemption of State Law Claims under the Medical Devices Amendments (MDA)

Application: The court applied the Fifth Circuit's clarification to determine that state law claims for defective design were not preempted by the MDA, as the specific design of the Class III device was not regulated by federal law.

Reasoning: The Fifth Circuit determined that state claims for failure to warn and defective design were not preempted since the specific design of the device was not covered by federal regulations.

Non-applicability of Precedent from Lewis v. Intermedics Intraocular, Inc.

Application: The court determined that the precedent set in Feldt, rather than Lewis, governs this case, as Lewis focused on a different legal question concerning informed consent.

Reasoning: The court found the defendants' reliance on the Fifth Circuit's opinion in Lewis v. Intermedics Intraocular, Inc. to be unpersuasive.

Remand to State Court

Application: The court vacated its prior order and remanded the case to state court, concluding that the plaintiffs adequately stated claims not preempted by federal law.

Reasoning: The United States District Court for the Eastern District of Louisiana vacated its prior order denying the plaintiffs' motion to remand the case... and remanded the action back to state court.